JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

Search

CASI Pharmaceuticals Inc

Open

1.29 -5.84

Overview

Share price change

24h

Current

Min

1.29

Max

1.37

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+187.77% upside

Dividends

By Dow Jones

Next Earnings

13 Nov 2025

CASI Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Nov 2025, 21:44 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 Nov 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 Nov 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 Nov 2025, 23:28 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 Nov 2025, 23:24 UTC

Earnings

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 Nov 2025, 23:14 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

3 Nov 2025, 23:14 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 Nov 2025, 23:12 UTC

Earnings

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 Nov 2025, 23:09 UTC

Earnings

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 Nov 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 Nov 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 Nov 2025, 23:06 UTC

Market Talk
Earnings

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 Nov 2025, 22:36 UTC

Market Talk
Earnings

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 Nov 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q EPS $1.49 >FNV

3 Nov 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q Rev $487.7M >FNV

3 Nov 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 Nov 2025, 22:19 UTC

Acquisitions, Mergers, Takeovers

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 Nov 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 Nov 2025, 21:54 UTC

Market Talk
Earnings

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 Nov 2025, 21:54 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

3 Nov 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 Nov 2025, 21:49 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 Nov 2025, 21:40 UTC

Earnings

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 Nov 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 Nov 2025, 21:19 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 Nov 2025, 21:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 Nov 2025, 21:11 UTC

Earnings

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 Nov 2025, 21:07 UTC

Earnings

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 Nov 2025, 21:05 UTC

Earnings

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 Nov 2025, 21:05 UTC

Earnings

Palantir Technologies 3Q Net $475.6M >PLTR

Peer Comparison

Price change

CASI Pharmaceuticals Inc Forecast

Price Target

By TipRanks

187.77% upside

12 Months Forecast

Average 4 USD  187.77%

High 4 USD

Low 4 USD

Based on 1 Wall Street analysts offering 12 month price targets forCASI Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Financials

$

help-icon Live chat